Parvexon Plus-Injection-100ml

Description

Parvexon® Plus – Features & Description

Active Ingredients & Formulation

• Parvaquone – 150 mg/mL (theilericidal agent targeting schizonts and piroplasms)

• Frusemide – 55 mg/mL (potent loop diuretic designed to relieve pulmonary edema)

• Ready-to-use, single injectable oil-based solution for intramuscular administration

Indications & Uses

• Primary Use: Treats East Coast Fever (Theileriosis) in cattle

• Special Role: Specifically formulated for advanced ECF with pulmonary edema, addressing both the parasitic infection and its respiratory complications

Key Benefits

• Dual-Action Formula:

  • Parvaquone disrupts theilerial parasites in multiple stages

  • Frusemide quickly reduces lung fluid accumulation, leading to faster recovery from respiratory distress

• Improved Cure Rates:

  • Clinical trials in Tanzania showed an 89% cure rate in severe but uncomplicated cases with Parvaquone+Frusemide, compared to 40% using parvaquone alone

  • Overall survival better than parvaquone alone (77% vs. 71%)

• Pulmonary Symptom Relief: Onset of improvement in 24–48 hours due to diuretic effect

 Dosage & Administration

• Dose: 1 mL per 15 kg body weight (≈10 mg parvaquone + 3.6 mg frusemide per kg)

• Route: Intramuscular injection into neck muscles

• Repeat: After 48 hours; in severe cases with pulmonary edema, continue daily at half-dose intervals after initial treatment

 Pack Sizes & Withdrawal

• Vials Available:

  • 50 mL (72 per case)

  • 100 mL (48 per case)

• Withdrawal Periods:

  • Meat/offal: 28 days

  • Milk: 14 days

Features Summary Table